Bristol-Myers Squibb Co. (BMY)
Healthcare – PHARMACEUTICAL PREPARATIONS
- CEO
- Chris Boerner
- Headquarters
- United States
- Employees
- 32,500
- Market Cap
- $128.9B
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
SentiSense also tracks daily options readings for Bristol-Myers Squibb Co.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Bristol-Myers Squibb Co. stock analysis, sentiment tracking, and market intelligence on SentiSense.